Aug 27, 2024 / 01:00AM GMT
Thomas Culver - Pharmx Technologies Ltd - Chief Executive Officer
My name is Tom Culver. I'm the CEO of PharmX. And today, we'll be taking you through a couple of key areas in our presentation, an overview of the business today, our results, and (technical difficulty) FY25. I'll hand it over to Jon to introduce himself.
Andrew Jonathan George Newbery - Pharmx Technologies Ltd - Interim Chief Financial Officer, Executive Director
Morning, everyone. I'm Jon Newbery. As many of you know, I'm standing in for Zoe Hillier, who's away on maternity leave, as the CFO. And I'm delighted to be here this morning and look forward to talking you through the financial results for the financial year ended June 30, 2024, little bit later.
Thomas Culver - Pharmx Technologies Ltd - Chief Executive Officer
Thank you, Jon. And then, just a last comment you can hold any questions until the end. We've got plenty of time for Q&A. Please feel free to put in (technical difficulty), we'll address those as we go. And if everybody could kindly
Full Year 2024 Pharmx Technologies Ltd Earnings Call Transcript
Aug 27, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers